Navigation Links
NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting
Date:3/4/2009

tes very low variability of the results. Unlike these 2-D approaches, QTinno can extract previously unavailable diagnostic data in milliseconds, utilizing all data to obtain a 3-dimensional view of the cardiac activity. It does this without changing any of the standard practices of ECG collection."

Dr. Vajdic added, "In an increasingly challenging clinical research and drug development environment, pharmaceutical companies continue to look for ways to increase efficiency, accelerate drug development, and reduce the costs of drug development, and Contract Research Organizations seek competitive advantages to maintain profit margins and capture market share. NewCardio's proven ability to process electrocardiographic results with unrivaled accuracy in a fully automated fashion provides the ideal solution for these industry-wide challenges. We look forward to sharing the results of this study at this and other prestigious conferences, as well as in peer-reviewed journals."

About NewCardio, Inc.

NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology to provide higher accuracy to, and increase the value of, the standard 12-lead electrocardiogram (ECG). NewCardio's development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease (CVD), as well as cardiac safety assessment of drugs under development. NewCardio's three-dimensional ECG platform is designed to reduce the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. For more information, visit www.newcardio.com.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NewCardio Announces New Client Services Team
2. NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure
3. NewCardio to Present at OneMedForum 2009: Disrupters and Drivers on January 13 in San Francisco
4. Yakima Health Care Leader Tapped for Leadership Post at National Association
5. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
6. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation
7. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
8. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
9. Blue Care Network of Michigan Earns National Leadership Award for Chronic Disease Management
10. Schooner Healthcare Services, LLC Announces New Leadership Team
11. National Quality Forum Announces New Member Councils Leadership

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...were treated with cisplatin-based chemotherapy had...side effects and Raynaud-like phenomena, than men ...to a new study published online November 25 in the...arianne Brydy, M.D., of the Department of Oncology..., and colleagues conducted a cross-sectional study...
(Date:11/25/2009)...w definite conclusions, experts say, , ,...ic patients with blocked coronary arteries, there ...r whether patients undergo bypass surgery or angio..., Bypass surgery has been the standard treatmen...se. However, less invasive approaches such as angi...
(Date:11/25/2009)...s, study finds , , WEDNESDAY, Nov. 25 (...mong the potential problems faced by long-term sur...cisplatin-based chemotherapy, a new study has foun...ated for unilateral testicular cancer between 1980...ucted from 1998 to 2002. , The researchers foun...
(Date:11/25/2009)...htYear ,, WASHINGTON,Nov.25/PRNewswire-USNews...ssuedthe 4thAnnualReportCardonLungCancer .ThisRepo...aldiseaseinthestateofGeorgia.LCA-GAisachapterofLun...dicatedexclusivelytopatientsupportandadvocacyforpe...http://www.newscom.com/cgi-bin/prnh/20081016/LCALO...
(Date:11/25/2009)... cells, study finds , , WEDNESDAY, Nov. ...in a fingernail-size implant eliminated melanoma t...d uses polymer disks, 8.5 millimeters in diameter,...implanted under the skin to reprogram the immune s...entists who developed the implant predicted that i...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...ree condoms for nearly 9 months will soon be provi.../ the New York city logo as a promotional offer. M...uted since June, according to health officials. ...r would materialise in the next couple of months. ...
...cted that by 2020 road accidents will be the third...c health issues like tuberculosis, diarrhoea and H...atalities are expected to increase from 135,000 in...n' released Tuesday. Around 85 percent of th...
...tival, hot air balloon festival for 2 weeks, inaug...as been the joint efforts of Rajasthan Tourism and...ling from 11countries are participating, who will ... hot air balloons, the locale of Rajasthan making ...
...on has been confirmed in Greece, Bulgaria and Sl...ve been initiated by the Italian following detecti... br> The EU confirmed that samples sent to its ...eece. A spokesman said that in keeping with E...
...ll condoms in school through installation of condo... largest political party in Australia.// Ka... Australia's state parliament, said the issue was ...they are certainly telling their friends. We can't...
...riage) is thought to bring an increased number of ...ge lead to betterment in the health of both sexes ...y couples also offer numerous advantages. Prof...alth said that such marriages apart from health be...
Other Medicine News:Health News:Road accidents greater threat than AIDS, TB: WHO 2
(Date:11/25/2009)...FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicald...ydisruptivesurgicaltreatmentsforthespine,announced...r30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecall...theCompany,sproductsandwillincludecommentsfrommana...dial-innumbersare1-877-407-4018fordomesticcallersa...
(Date:11/25/2009)...-Reportlinker.comannouncesthatanewmarketresearchre...ugDelivery-USMarketTrends&Analysis http://www...y---US-Market-Trends--Analysis.html ,, TheUSin...ftherapeuticapplicationsfromthedeliveryofconventio...rapeuticdrugs.Thefutureofthetechnologyhingesontoth...
(Date:11/25/2009)...PRNewswire/-- ChemoCentryx,Inc.,announcedtodaytha...theProspectiveRandomizedOralTherapyEvaluationinCro...entswithmoderate-to-severeCrohn,sdiseasedemonstrat...ityprofile.Thestudydemonstratedevidenceofclinicale...70-pointdecreaseintheCrohn,sDiseaseActivityIndex(C...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 1Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 2Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 3Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 4Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 5Heart Disease Treatment Breakthrough 4495 1Heart Disease Treatment Breakthrough 4495 2Heart Disease Treatment Breakthrough 4495 3TNFerade 28TM 29 Phase III Data Presented at ASCO 4493 1TNFerade 28TM 29 Phase III Data Presented at ASCO 4493 2TNFerade 28TM 29 Phase III Data Presented at ASCO 4493 3
...ew released today by HHS, Agency for Healthcare Re...fit is lacking for many common ways of,treating os...y supplement,ingredients, a common surgical proced...that glucosamine and chondroitin, over-the-counter...ly because of their,purported benefits to relieve ...
...ty of America (IDSA) 45TH ..., Inc. today announced,results from two important ...Society of America (IDSA) 45th Annual Meeting addi...ytial virus (RSV). RSV is a viral,pathogen that pr...pring.,While RSV typically manifests cold-like sym...
Other Medicine Technology:Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee 2MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results 2MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results 3MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results 4
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: